Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 11:12:620566.
doi: 10.3389/fendo.2021.620566. eCollection 2021.

The Centrality of Obesity in the Course of Severe COVID-19

Danfei Liu  1 , Tongyue Zhang  1 , Yijun Wang  1 , Limin Xia  1
Affiliations
Review

The Centrality of Obesity in the Course of Severe COVID-19

Danfei Liu et al. Front Endocrinol (Lausanne). .

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global public health challenge. Most patients do not experience severe complications, but approximately 25% of patients progress to acute respiratory distress syndrome (ARDS), and the mortality rate is approximately 5-7%. Clinical findings have determined several risk factors for severe complications and mortality in COVID-19 patients, such as advanced age, smoking, obesity, and chronic diseases. Obesity is a common and serious health problem worldwide that initiates a cascade of disorders, including hypertension, cardiovascular disease (CVD), diabetes mellitus, and chronic kidney disease (CKD). The presence of these disorders is linked to a more severe course of COVID-19. Given the "epidemic" of obesity worldwide and the importance of obesity in the progression of COVID-19, we investigated the mechanisms through which obesity increases the susceptibility to and severity of COVID-19 to support the selection of more appropriate therapies for individuals with obesity.

Keywords: COVID-19; obesity; obesity-associated comorbidities; pathophysiology; therapeutic strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The centrality of obesity in the course of severe COVID-19. Schematic demonstrating the interaction between obesity and multiple body systems, contributing to severe COVID-19.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’ Donnell LF, Chernyak Y, et al. . Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. BMJ (2020) 369:m1966. 10.1136/bmj.m1966 - DOI - PMC - PubMed
    1. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. . Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ (2020) 369:m1985. 10.1136/bmj.m1985 - DOI - PMC - PubMed
    1. Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE, Vargas-Vazquez A, Gonzalez-Diaz A, Marquez-Salinas A, et al. . Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab (2020) 105(8):2752–61. 10.1210/clinem/dgaa346 - DOI - PMC - PubMed
    1. Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL. Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50. Obes (Silver Spring) (2020) 28(9):1595–9. 10.1002/oby.22913 - DOI - PMC - PubMed
    1. Hruby A, Hu FB. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics (2015) 33(7):673–89. 10.1007/s40273-014-0243-x - DOI - PMC - PubMed

Publication types